President Trump on Thursday announced another deal to cut pharmaceutical costs for Americans with most favored nation (MFN) pricing on popular drugs for diabetes, heart disease, and weight loss, and other conditions. According to the White House, “The agreement represents a historic reduction in prices for Americans on the two drugs with the highest annual expenditures in the United States, both of which help adults struggling with diabetes, heart disease (Ozempic and Wegovy only), obesity, and other conditions.” The drugs will be available on TrumpRX.com, a federal government website that will help patients buy drugs directly from pharmaceutical companies without using insurance, at massively discounted prices, in line with what other countries pay for the same drugs. But Medicare and Medicaid will also cover these…
Click here to read the full article at The Gateway Pundit.
